Sanofi Is Exploring Acquisition of Cancer Drugmaker Mirati

📆 05/10/2023 11:19 م
📰 YahooFinanceCA

⏱ Reading Time:
14 sec. here
2 min. at publisher
📊 Quality Score:
News: 9%
Publisher: 63%

مصر أخبار أخبار

مصر أحدث الأخبار,مصر عناوين

(Bloomberg) -- French pharmaceutical giant Sanofi is exploring a potential acquisition of cancer drugmaker Mirati Therapeutics Inc., according to people familiar with the matter.Most Read from BloombergAlmost Anyone Can Become the House Speaker, Except Donald TrumpOzempic Is Making People Buy Less Food, Walmart SaysOnly an Equities Crash Can Rescue the Bond Market, Barclays SaysThe Moral Case for No Longer Engaging With Elon Musk’s XIt's Done. The Future Is Battery-Powered Electric CarsMirati’s

-- French pharmaceutical giant Sanofi is exploring a potential acquisition of cancer drugmaker Mirati Therapeutics Inc., according to people familiar with the matter.It's Done. The Future Is Battery-Powered Electric Cars

Deliberations are ongoing and there’s no certainty they will result in an agreement. Mirati could also attract interest from other suitors, the people said. A sale would give Mirati further resources to help it commercialize the treatment and fund further studies.

لقد قمنا بتلخيص هذا الخبر حتى تتمكن من قراءته بسرعة. إذا كنت مهتمًا بالأخبار، يمكنك قراءة النص الكامل هنا. اقرأ أكثر:

اكتب تعليق

مصر أحدث الأخبار, مصر عناوين

Similar News:يمكنك أيضًا قراءة قصص إخبارية مشابهة لهذه التي قمنا بجمعها من مصادر إخبارية أخرى.

Sanofi to explore acquisition of cancer drugmaker Mirati\u002D Bloomberg NewsExplore stories from Atlantic Canada.
مصدر: SaltWire Network - 🏆 45. / 63 اقرأ أكثر »